Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRDF Cardiff Oncology, Inc.

盘前交易 04-26 04:45:37 EDT

3.99

-0.19

-4.55%

最高4.20	最低3.95	成交量58.66万
今开4.12	昨收4.18	日振幅5.98%
总市值1.78亿	流通市值1.65亿	总股本4,468万
成交额237.52万	换手率1.42%	流通股本4,129万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRDF","market":"US","secType":"STK","nameCN":"Cardiff Oncology, Inc.","latestPrice":3.99,"timestamp":1714075200000,"preClose":4.18,"halted":0,"volume":586641,"delay":0,"floatShares":41292457,"shares":44677169,"eps":-0.93,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.19,"latestTime":"04-26 04:45:37 EDT","open":4.12,"high":4.2,"low":3.95,"amount":2375191.494159,"amplitude":0.059809,"askPrice":4.66,"askSize":100,"bidPrice":3.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.93,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714138200000},"adr":0,"listingDate":1059624000000,"adjPreClose":3.99,"postHourTrading":{"tag":"盘后","latestPrice":4.08,"preClose":3.99,"latestTime":"18:39 EDT","volume":5628,"amount":22517.355,"timestamp":1714084749750},"volumeRatio":0.9946877954279838},"requestUrl":"/m/hq/s/CRDF","defaultTab":"news","newsList":[{"id":"2429114934","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429114934","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429114934?lang=zh_cn&edition=full","pubTime":"2024-04-23 23:33","pubTimestamp":1713886439,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日23时33分，Cardiff Oncology, Inc.股票出现异动，股价快速下挫5.28%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232333597a54f2f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232333597a54f2f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428512248","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428512248","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428512248?lang=zh_cn&edition=full","pubTime":"2024-04-19 00:50","pubTimestamp":1713459003,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日00时50分，Cardiff Oncology, Inc.股票出现波动，股价快速下跌5.33%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为9340.26%、104.25%、41.08%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Aileron Therapeutics, Inc.，振幅分别为86.72%、73.93%、68.47%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419005003792195f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419005003792195f8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428934425","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大跌5.01%报4.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428934425","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428934425?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:35","pubTimestamp":1713364511,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时35分，Cardiff Oncology, Inc.股票出现异动，股价快速下跌5.01%。截至发稿，该股报4.36美元/股，成交量17.8627万股，换手率0.40%，振幅6.75%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041722351187e81660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041722351187e81660&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427878240","title":"Cardiff Oncology, Inc.盘中异动 早盘快速跳水7.39%报4.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427878240","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427878240?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:50","pubTimestamp":1713275442,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时50分，Cardiff Oncology, Inc.股票出现异动，股价急速跳水7.39%。截至发稿，该股报4.89美元/股，成交量8.465万股，换手率0.19%，振幅3.79%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621504387e80fb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621504387e80fb6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427887346","title":"Cardiff Oncology, Inc.盘中异动 快速下挫5.06%报5.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427887346","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427887346?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:26","pubTimestamp":1713205610,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时26分，Cardiff Oncology, Inc.股票出现波动，股价急速下挫5.06%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1548.82%、1230.08%、867.88%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、114.53%、80.04%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041602265087e8085d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041602265087e8085d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427594407","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.11%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427594407","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427594407?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:40","pubTimestamp":1712947208,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时40分，Cardiff Oncology, Inc.股票出现异动，股价大幅跳水5.11%。截至发稿，该股报5.38美元/股，成交量58.263万股，换手率1.30%，振幅8.00%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130240097a527b89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130240097a527b89&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426265549","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大跌5.43%报5.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426265549","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426265549?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:19","pubTimestamp":1712845160,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时19分，Cardiff Oncology, Inc.股票出现异动，股价急速下挫5.43%。截至发稿，该股报5.57美元/股，成交量9.6908万股，换手率0.22%，振幅5.77%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411221921791ff28a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411221921791ff28a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426113892","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.10%报6.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426113892","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426113892?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:07","pubTimestamp":1712671635,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时07分，Cardiff Oncology, Inc.股票出现波动，股价急速上涨5.10%。截至发稿，该股报6.18美元/股，成交量18.9906万股，换手率0.43%，振幅5.22%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409220715791f6be9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409220715791f6be9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425905759","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.21%报6.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425905759","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425905759?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:35","pubTimestamp":1712583349,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时35分，Cardiff Oncology, Inc.股票出现波动，股价大幅上涨5.21%。截至发稿，该股报6.14美元/股，成交量4.1004万股，换手率0.09%，振幅2.65%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821355087e7e8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821355087e7e8bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425563044","title":"Cardiff Oncology, Inc.盘中异动 急速上涨5.20%报5.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425563044","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425563044?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:37","pubTimestamp":1712324274,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时37分，Cardiff Oncology, Inc.股票出现波动，股价大幅拉升5.20%。截至发稿，该股报5.97美元/股，成交量5.5577万股，换手率0.12%，振幅2.26%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052137557a5113bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052137557a5113bb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424946392","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424946392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424946392?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:31","pubTimestamp":1712237502,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时31分，Cardiff Oncology, Inc.股票出现异动，股价快速拉升5.07%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213142861e364e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213142861e364e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424049819","title":"Cardiff Oncology, Inc.盘中异动 急速跳水5.58%报5.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424049819","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424049819?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:56","pubTimestamp":1712066175,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时56分，Cardiff Oncology, Inc.股票出现波动，股价急速下挫5.58%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402215615791e7deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402215615791e7deb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422239940","title":"Cardiff Oncology, Inc.盘中异动 下午盘大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422239940","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422239940?lang=zh_cn&edition=full","pubTime":"2024-03-28 03:11","pubTimestamp":1711566687,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日03时11分，Cardiff Oncology, Inc.股票出现异动，股价快速上涨5.19%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328031128791d52be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328031128791d52be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422662640","title":"Cardiff Oncology, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422662640","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422662640?lang=zh_cn&edition=full","pubTime":"2024-03-27 01:46","pubTimestamp":1711475171,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日01时46分，Cardiff Oncology, Inc.股票出现异动，股价急速跳水5.08%。截至发稿，该股报5.61美元/股，成交量64.3543万股，换手率1.44%，振幅7.58%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032701461287e7be80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032701461287e7be80&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422548108","title":"Cardiff Oncology, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422548108","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422548108?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373493,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分，Cardiff Oncology, Inc.股票出现波动，股价大幅拉升5.11%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为793.50%、47.09%、31.04%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Ocugen, Inc.，振幅分别为21.97%、15.26%、8.53%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521313487e7b778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521313487e7b778&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421811078","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421811078","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421811078?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:50","pubTimestamp":1711115402,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时50分，Cardiff Oncology, Inc.股票出现波动，股价急速上涨5.04%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222150037a4e8a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222150037a4e8a6e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421491700","title":"Cardiff Oncology, Inc.盘中异动 股价大涨5.24%报5.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421491700","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421491700?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:43","pubTimestamp":1711028601,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时43分，Cardiff Oncology, Inc.股票出现波动，股价大幅拉升5.24%。截至发稿，该股报5.22美元/股，成交量8.038万股，换手率0.18%，振幅4.43%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121432187e7ab8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121432187e7ab8c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420772310","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.75%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420772310","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420772310?lang=zh_cn&edition=full","pubTime":"2024-03-20 22:08","pubTimestamp":1710943683,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日22时08分，Cardiff Oncology, Inc.股票出现波动，股价大幅拉升5.75%。截至发稿，该股报5.15美元/股，成交量12.8689万股，换手率0.29%，振幅9.24%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320220804791bbfb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320220804791bbfb9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420527886","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420527886","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420527886?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:04","pubTimestamp":1710857063,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时04分，Cardiff Oncology, Inc.股票出现波动，股价大幅跳水5.05%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Enliven Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为720.09%、340.37%、132.33%，振幅较大的相关个股有Enveric Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Hoth Therapeutics, Inc.，振幅分别为44.55%、30.00%、27.83%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319220423861df6c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319220423861df6c5&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardiffoncology.com","stockEarnings":[{"period":"1week","weight":-0.087},{"period":"1month","weight":-0.2597},{"period":"3month","weight":1.6779},{"period":"6month","weight":2.8},{"period":"1year","weight":1.5909},{"period":"ytd","weight":1.6959}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cardiff Oncology, Inc.是一家出于发展阶段的分子诊断公司，专注由专有产权的诊断技术的开发和市场推广，这种技术在各种医学诊所用于患者/疾病的扫描和监视。公司主要的内部焦点是操作新型的尿液分子诊断平台，以促进在治疗肿瘤领域的进步，外部焦点包括了在传染病、移植医疗和产前诊断领域发展合作。公司于2002年4月26日以Used Kar Parts公司之名成立于弗罗里达。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.0094},{"month":2,"riseRate":0.416667,"avgChangeRate":0.317908},{"month":3,"riseRate":0.416667,"avgChangeRate":0.122926},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.073299},{"month":5,"riseRate":0.454545,"avgChangeRate":0.064115},{"month":6,"riseRate":0.454545,"avgChangeRate":0.374334},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.076398},{"month":8,"riseRate":0.666667,"avgChangeRate":0.1282},{"month":9,"riseRate":0.25,"avgChangeRate":0.007515},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.043116},{"month":11,"riseRate":0.416667,"avgChangeRate":0.053966},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.087919}],"exchange":"NASDAQ","name":"Cardiff Oncology, Inc.","nameEN":"Cardiff Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cardiff Oncology, Inc.,CRDF,Cardiff Oncology, Inc.股票,Cardiff Oncology, Inc.股票老虎,Cardiff Oncology, Inc.股票老虎国际,Cardiff Oncology, Inc.行情,Cardiff Oncology, Inc.股票行情,Cardiff Oncology, Inc.股价,Cardiff Oncology, Inc.股市,Cardiff Oncology, Inc.股票价格,Cardiff Oncology, Inc.股票交易,Cardiff Oncology, Inc.股票购买,Cardiff Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}